These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Anticholangiocarcinoma activity and toxicity of the Kaempferia galanga Linn. Rhizome ethanolic extract. Amuamuta A; Plengsuriyakarn T; Na-Bangchang K BMC Complement Altern Med; 2017 Apr; 17(1):213. PubMed ID: 28403856 [TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity, toxicity, and anticancer activity of Zingiber officinale Roscoe against cholangiocarcinoma. Plengsuriyakarn T; Viyanant V; Eursitthichai V; Tesana S; Chaijaroenkul W; Itharat A; Na-Bangchang K Asian Pac J Cancer Prev; 2012; 13(9):4597-606. PubMed ID: 23167387 [TBL] [Abstract][Full Text] [Related]
6. Anticancer activities against cholangiocarcinoma, toxicity and pharmacological activities of Thai medicinal plants in animal models. Plengsuriyakarn T; Viyanant V; Eursitthichai V; Picha P; Kupradinun P; Itharat A; Na-Bangchang K BMC Complement Altern Med; 2012 Mar; 12():23. PubMed ID: 22448640 [TBL] [Abstract][Full Text] [Related]
7. The anticancer effects of Resina Draconis extract on cholangiocarcinoma. Wen F; Zhao X; Zhao Y; Lu Z; Guo Q Tumour Biol; 2016 Nov; 37(11):15203-15210. PubMed ID: 27683055 [TBL] [Abstract][Full Text] [Related]
8. Actinidia arguta (Hardy Kiwi) Root Extract Exerts Anti-cancer Effects via Mcl-1-Mediated Apoptosis in Cholangiocarcinoma. Zhao X; Wen F; Wang W; Lu Z; Guo Q Nutr Cancer; 2019; 71(2):246-256. PubMed ID: 30633583 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of Tumor Growth against Chemoresistant Cholangiocarcinoma by a Proapoptotic Peptide Targeting Interleukin-4 Receptor. Permpoon U; Khan F; Vadevoo SMP; Gurung S; Gunassekaran GR; Kim MJ; Kim SH; Thuwajit P; Lee B Mol Pharm; 2020 Nov; 17(11):4077-4088. PubMed ID: 32881535 [TBL] [Abstract][Full Text] [Related]
10. In vitro cytotoxic and toxicological activities of ethanolic extract of Kaempferia galanga Linn. and its active component, ethyl-p-methoxycinnamate, against cholangiocarcinoma. Tritripmongkol P; Plengsuriyakarn T; Tarasuk M; Na-Bangchang K J Integr Med; 2020 Jul; 18(4):326-333. PubMed ID: 32418766 [TBL] [Abstract][Full Text] [Related]
11. Capsaicin Enhances the Drug Sensitivity of Cholangiocarcinoma through the Inhibition of Chemotherapeutic-Induced Autophagy. Hong ZF; Zhao WX; Yin ZY; Xie CR; Xu YP; Chi XQ; Zhang S; Wang XM PLoS One; 2015; 10(5):e0121538. PubMed ID: 25933112 [TBL] [Abstract][Full Text] [Related]
12. Raddeanin A promotes apoptosis and ameliorates 5-fluorouracil resistance in cholangiocarcinoma cells. Guo SS; Wang Y; Fan QX World J Gastroenterol; 2019 Jul; 25(26):3380-3391. PubMed ID: 31341363 [TBL] [Abstract][Full Text] [Related]
13. Thymosin β10 as a predictive biomarker of response to 5-fluorouracil chemotherapy in cholangiocarcinoma. Sribenja S; Natthasirikul N; Vaeteewoottacharn K; Sawanyawisuth K; Wongkham C; Jearanaikoon P; Wongkham S Ann Hepatol; 2016; 15(4):577-85. PubMed ID: 27236157 [TBL] [Abstract][Full Text] [Related]
14. FOXM1 inhibitor, Siomycin A, synergizes and restores 5-FU cytotoxicity in human cholangiocarcinoma cell lines via targeting thymidylate synthase. Klinhom-On N; Seubwai W; Sawanyawisuth K; Obchoei S; Mahalapbutr P; Wongkham S Life Sci; 2021 Dec; 286():120072. PubMed ID: 34688691 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of anticancer potential of Thai medicinal herb extracts against cholangiocarcinoma cell lines. Promraksa B; Phetcharaburanin J; Namwat N; Techasen A; Boonsiri P; Loilome W PLoS One; 2019; 14(5):e0216721. PubMed ID: 31120926 [TBL] [Abstract][Full Text] [Related]
16. FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1-TYMS axis uncoupling in 5-FU resistance. Intuyod K; Saavedra-García P; Zona S; Lai CF; Jiramongkol Y; Vaeteewoottacharn K; Pairojkul C; Yao S; Yong JS; Trakansuebkul S; Waraasawapati S; Luvira V; Wongkham S; Pinlaor S; Lam EW Cell Death Dis; 2018 Dec; 9(12):1185. PubMed ID: 30538221 [TBL] [Abstract][Full Text] [Related]
17. Effect of histone deacetylase inhibitor in combination with 5-fluorouracil on pancreas cancer and cholangiocarcinoma cell lines. Iwahashi S; Ishibashi H; Utsunomiya T; Morine Y; Ochir TL; Hanaoka J; Mori H; Ikemoto T; Imura S; Shimada M J Med Invest; 2011 Feb; 58(1-2):106-9. PubMed ID: 21372494 [TBL] [Abstract][Full Text] [Related]
18. Cratoxylum formosum Extracts Inhibit Growth and Metastasis of Cholangiocarcinoma Cells by Modulating the NF-κB and STAT3 Pathways. Senggunprai L; Thammaniwit W; Kukongviriyapan V; Prawan A; Kaewseejan N; Siriamornpun S Nutr Cancer; 2016; 68(2):328-41. PubMed ID: 26908056 [TBL] [Abstract][Full Text] [Related]
19. TRAIL in Combination with Subtoxic 5-FU Effectively Inhibit Cell Proliferation and Induce Apoptosis in Cholangiocarcinoma Cells. Sriraksa R; Limpaiboon T Asian Pac J Cancer Prev; 2015; 16(16):6991-6. PubMed ID: 26514480 [TBL] [Abstract][Full Text] [Related]
20. Upregulation of retinoic acid receptor-β reverses drug resistance in cholangiocarcinoma cells by enhancing susceptibility to apoptosis. Ren HY; Chen B; Huang GL; Liu Y; Shen DY Mol Med Rep; 2016 Oct; 14(4):3602-8. PubMed ID: 27599527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]